• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

Comprehensive Overview of 1H-Benzimidazole-2-propanamine,5-methyl-(9CI) (CAS No. 630091-53-1): Properties, Applications, and Industry Insights

1H-Benzimidazole-2-propanamine,5-methyl-(9CI), identified by its CAS No. 630091-53-1, is a specialized organic compound belonging to the benzimidazole derivatives family. This heterocyclic structure features a methyl-substituted benzimidazole core linked to a propanamine side chain, offering unique chemical properties that make it valuable in pharmaceutical and material science research. The compound’s molecular formula, C₁₁H₁₅N₃, highlights its nitrogen-rich composition, which contributes to its reactivity and binding affinity in biological systems.

In recent years, the demand for benzimidazole derivatives has surged due to their versatility in drug discovery. Researchers frequently search for "benzimidazole-based kinase inhibitors" or "small molecule modulators for metabolic diseases," reflecting the growing interest in targeted therapies. 1H-Benzimidazole-2-propanamine,5-methyl-(9CI) is often explored for its potential as a scaffold for anticancer agents or anti-inflammatory compounds, aligning with trends in precision medicine. Its structural flexibility allows modifications to enhance bioavailability or selectivity, addressing common challenges like "improving drug half-life" or "reducing off-target effects."

The compound’s physicochemical properties, including a moderate logP value and hydrogen-bonding capacity, make it suitable for high-throughput screening (HTS) in drug development. Laboratories frequently inquire about "solubility of benzimidazole derivatives" or "stability under physiological conditions," which are critical for formulation studies. CAS No. 630091-53-1 has also been investigated in materials science, particularly in designing organic semiconductors or ligands for catalytic systems, responding to the rise in green chemistry initiatives.

From a synthetic perspective, 1H-Benzimidazole-2-propanamine,5-methyl-(9CI) can be prepared via cyclocondensation reactions or functional group transformations, methods often queried in academic forums. Optimizing its yield and purity is a recurring topic, with searches like "benzimidazole synthesis troubleshooting" or "chromatography purification techniques." The compound’s NMR and MS spectra are well-documented, aiding in quality control—a key concern for manufacturers ensuring batch-to-batch consistency.

Regulatory and safety profiles of CAS No. 630091-53-1 adhere to standard laboratory handling protocols. While not classified as hazardous, users often seek "benzimidazole derivative storage guidelines" or "compatibility with common lab solvents," emphasizing the need for clear technical documentation. The compound’s stability under inert atmospheres and recommended storage at -20°C are frequently cited in safety data sheets.

Market analyses indicate expanding applications for 5-methyl-substituted benzimidazoles, driven by advancements in personalized medicine and bioconjugation technologies. Patent landscapes reveal its use in proteolysis-targeting chimeras (PROTACs) and fluorescent probes, areas gaining traction in 2024. Queries such as "emerging uses of benzimidazole cores" or "intellectual property trends in heterocycles" reflect industry curiosity.

In conclusion, 1H-Benzimidazole-2-propanamine,5-methyl-(9CI) (CAS No. 630091-53-1) represents a multifaceted tool for researchers. Its relevance spans from hit-to-lead optimization to functional material design, addressing contemporary needs like "cost-effective synthetic routes" and "sustainable chemical processes." As interdisciplinary studies grow, this compound will likely remain pivotal in bridging chemistry with life sciences and nanotechnology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)